ASCVD Prevention for the Primary Care Provider Part 3: Secondary Prevention and Continuing Care
REGISTRATION PROGRAMME PRE-ASSESSMENT TEST
PRE-ASSESSMENT TEST
https://www.surveys.acc.org/se
The programme is supported with educational grant by Pfizer.
ASCVD Prevention for the Primary Care Provider Part 3: Secondary Prevention and Continuing Care
Venue: City Hall Volgograd (400074, 18 Raboche-Krestyanskaya st. Volgograd)
Tuesday, October 8th, 2019, 10:00-12:30 Moscow time
FACULTY EXPERTS
|
Russian Society of Cardiology (RSC)
Yury M. Lopatin, MD, PhD, FHFA Professor of Medicine Volgograd State Medical University
Serge V. Nedogoda, MD, PhD, FESC Professor of Medicine Volgograd State Medical University |
American College of Cardiology (ACC)
Aaron D. Kugelmass, MD, FACC Professor of Medicine University of Massachusetts, Baystate
Tracy Wang, MD, MHS, MSc, FACC Professor of Medicine Duke University |
PROGRAM AGENDA
|
Session |
Facilitators |
Time |
|
Opening Remarks |
Dr. Lopatin Dr. Kugelmass
|
10.00-10.05 |
|
Case Presentation & Discussion #1 |
|
10.05-10.50 |
|
12 months P2y12 duration post-ACS
Anticoagulation and antiplatelet decision-making for patients with ACS and AF
|
Dr. Wang Prof. Lopatin
|
|
|
Case Presentation & Discussion #2 |
|
10.50-11.35 |
|
Understanding and counteracting medication non-adherence in the post-MI patient
Misconceptions regarding statin safety for secondary prevention patients
|
Dr. Kugelmass Prof. Lopatin |
|
|
Case Presentation & Discussion #3 |
|
11.35-12.20 |
|
Arterial hypertension and diabetes
Are there any differences in Guidelines regarding the management of these patients? |
Prof. Nedogoda Dr. Lopatin
|
|
|
Closing Remarks
|
Dr. Kugelmass Dr. Lopatin |
12.20-12.30 |